Sign In
Buy JNJ
$231.29
+2.90 (+1.27%)
At Close: Jun 22, 2026
The Dividend Strategy That Beats the 4% Rule by $400,000 Over 20 Years on a $1 Million Portfolio
11:46am, Tuesday, 09'th Jun 2026
A 65-year-old retiree with $1 million who follows the standard 4% rule withdraws $40,000 in the first year, then increases that amount over time to keep pace with inflation. A dividend-focused alterna
Middle East Erupts Again: Buy these Healthcare ETFs Before the Next Strike
11:01am, Tuesday, 09'th Jun 2026
Healthcare ETFs are gaining attention as Middle East tensions and market volatility boost demand for defensive sectors.
Will Johnson & Johnson Stock Hit $300 This Year?
10:06am, Tuesday, 09'th Jun 2026
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) has rallied 13.73% year to date and 55.27% over the past year, fueled by oncology blockbusters and a MedTech franchise hitting on every cylinder.
Dividend Safety Check: SPDV and the High-Dividend Value Approach
10:00am, Tuesday, 09'th Jun 2026
The AAM S&P 500 High Dividend Value ETF (NYSEARCA:SPDV) screens the S&P 500 for stocks combining the highest yields with the strongest value characteristics, then caps sector exposure to prevent conce
Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying
09:20am, Tuesday, 09'th Jun 2026
More employers and health plans are balking at paying for costly GLP-1 drugs like Ozempic, Zepbound and Wegovy for weight loss and the treatment of obesity, according to a new report.
The Cash-Return Pivot: 5 Companies Hiking Dividends Right Now
08:04am, Tuesday, 09'th Jun 2026
S&P 500 companies are pivoting hard back to shareholder returns, and the dividend declarations rolling in this spring have already locked in record-breaking streaks.
A Portfolio That Doubles Your Social Security Check—and Your Spouse’s
07:36am, Tuesday, 09'th Jun 2026
A $1.2 million portfolio generating $7,200 per month produces $86,400 in annual income, equivalent to a blended yield of 7.2%. According to the Social Security Administration's 2026 COLA fact sheet, t
Get Paid Like an Indiana Police Officer With $5,000 a Month in Dividend Income After Taxes
05:08am, Tuesday, 09'th Jun 2026
Five thousand dollars a month in spendable dividend income works out to $60,000 per year after federal tax, roughly equivalent to the salary of a typical police officer in Indiana. The headline yield
Prediction: The Trump Bull Market Will Soon End -- But These 2 Stocks Will Keep Winning Anyway
06:15pm, Monday, 08'th Jun 2026
The S&P 500 has climbed in the double digits since President Donald Trump's inauguration. But certain elements point toward a potential slowdown ahead.
The Dividend Growth Portfolio That Starts at $40,000 a Year and Ends at $150,000
01:34pm, Monday, 08'th Jun 2026
A retiree's $40,000 dividend income stream sounds modest next to a neighbor's $90,000. But the growth rate often matters more than the starting number. A portfolio generating $40,000 today that grows
How to Replace a Registered Nurse’s Salary with $7,500 a Month in Dividend Income
11:13am, Monday, 08'th Jun 2026
Generating $7,500 per month in dividend income requires producing $90,000 annually from an investment portfolio. That income level is roughly equivalent to the salary of a registered nurse, based on r
Johnson & Johnson to buy Firefly Bio for $1 billion
08:08am, Monday, 08'th Jun 2026
Johnson & Johnson said on Monday it will acquire biotech Firefly Bio for $1 billion in cash, as it looks to expand its cancer drug pipeline.
Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader Antibody Conjugate Platform
08:00am, Monday, 08'th Jun 2026
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced it has entered into a definitive agreement to acquire Firefly Bio, Inc., a biotechnology company advancing its propr
Why Johnson & Johnson May Be the Closest Thing Investors Can Find to a Bulletproof Dividend Stock
10:15am, Saturday, 06'th Jun 2026
When Tylenol pills were tampered with and tainted in 1982, Johnson & Johnson managed the setback in stride. More recently, the healthcare giant has been navigating legal issues related to talcum pow
J&J beats lawsuit alleging that talc caused three women's cancer
06:24pm, Friday, 05'th Jun 2026
A Los Angeles jury on Friday sided with Johnson & Johnson in a lawsuit by the families of three women who alleged that the company's talc products caused ovarian cancer, finding that J&J was not
